TG Therapeutics Inc (TGTX)
15.85
+2.19
(+16.03%)
USD |
NASDAQ |
May 01, 16:00
15.95
+0.10
(+0.63%)
After-Hours: 18:24
TG Therapeutics Revenue (Quarterly): 43.97M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.97M |
| September 30, 2023 | 165.82M |
| June 30, 2023 | 16.07M |
| March 31, 2023 | 7.803M |
| December 31, 2022 | 0.08M |
| September 30, 2022 | 0.094M |
| June 30, 2022 | 0.594M |
| March 31, 2022 | 2.016M |
| December 31, 2021 | 2.321M |
| September 30, 2021 | 2.03M |
| June 30, 2021 | 1.545M |
| March 31, 2021 | 0.793M |
| December 31, 2020 | 0.038M |
| September 30, 2020 | 0.038M |
| June 30, 2020 | 0.038M |
| March 31, 2020 | 0.038M |
| December 31, 2019 | 0.038M |
| September 30, 2019 | 0.038M |
| June 30, 2019 | 0.038M |
| March 31, 2019 | 0.038M |
| December 31, 2018 | 0.038M |
| September 30, 2018 | 0.038M |
| June 30, 2018 | 0.038M |
| March 31, 2018 | 0.038M |
| December 31, 2017 | 0.038M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.038M |
| June 30, 2017 | 0.038M |
| March 31, 2017 | 0.038M |
| December 31, 2016 | 0.0377M |
| September 30, 2016 | 0.0381M |
| June 30, 2016 | 0.0381M |
| March 31, 2016 | 0.0381M |
| December 31, 2015 | 0.0381M |
| September 30, 2015 | 0.0381M |
| June 30, 2015 | 0.0381M |
| March 31, 2015 | 0.0381M |
| December 31, 2014 | 0.0381M |
| September 30, 2014 | 0.0381M |
| June 30, 2014 | 0.0381M |
| March 31, 2014 | 0.0381M |
| December 31, 2013 | 0.0381M |
| September 30, 2013 | 0.0381M |
| June 30, 2013 | 0.0381M |
| March 31, 2013 | 0.0381M |
| December 31, 2012 | 0.019M |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.038M
Minimum
Jun 2019
165.82M
Maximum
Sep 2023
12.81M
Average
0.594M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 115.08M |
| Geron Corp | 0.023M |
| Editas Medicine Inc | 60.05M |
| G1 Therapeutics Inc | 14.87M |
| Mersana Therapeutics Inc | 10.70M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.42M |
| Total Expenses (Quarterly) | 56.46M |
| EPS Diluted (Quarterly) | -0.10 |
| Enterprise Value | 1.992B |
| Gross Profit Margin (Quarterly) | 82.14% |
| Profit Margin (Quarterly) | -32.79% |
| Earnings Yield | 0.06% |
| Operating Earnings Yield | 0.88% |
| Normalized Earnings Yield | 0.0631 |